MMedXYNews
HomeVideos
MedXY AI/MedXY News/Tag: risk stratification
MedXY News
EnglishTag

risk stratification

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationcritical carebiomarkersartificial intelligencetype 1 diabetesclinical trialsHypertensiononcologyCardiologyMortalitypublic healthcardiovascular diseasediabetesAlzheimer's diseasebreast cancerepidemiology

Latest news

Tag

Genotype and Arrhythmic Risk in Dilated Cardiomyopathy: An Integrative Review of Genetic Stratification and Clinical Implications
Cardiologygenetic riskDilated cardiomyopathy

Genotype and Arrhythmic Risk in Dilated Cardiomyopathy: An Integrative Review of Genetic Stratification and Clinical Implications

By MedXY|Oct 22, 2026

Genetic variants in dilated cardiomyopathy confer differential arrhythmic risks, independent of traditional clinical parameters. Integrating recent registry data and molecular studies enhances risk stratification and informs tailored manage

Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker in High-Risk Cutaneous Squamous Cell Carcinoma
Dermatology全身炎症
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
cutaneous squamous-cell carcinoma

Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker in High-Risk Cutaneous Squamous Cell Carcinoma

By MedXY|Oct 21, 2026

Preoperative neutrophil-to-lymphocyte ratio (NLR) predicts poor outcomes in high-risk cutaneous squamous cell carcinoma, offering a cost-effective tool to enhance risk stratification.

Adoption of Outpatient Management of Acute Low-Risk Pulmonary Embolism: Evidence, Implementation, and Future Directions
Cardiologypulmonary embolismrisk stratification

Adoption of Outpatient Management of Acute Low-Risk Pulmonary Embolism: Evidence, Implementation, and Future Directions

By MedXY|Oct 20, 2026

This review synthesizes evidence supporting outpatient management of acute low-risk pulmonary embolism (PE), highlighting risk stratification tools, safety outcomes, and implementation strategies to enhance adoption in clinical practice.

Refining Prognostication in Advanced Mycosis Fungoides and Sézary Syndrome: The Role of the Cutaneous Lymphoma International Prognostic Index (CLIPI)
DermatologyCutaneous lymphomaMycosis fungoides

Refining Prognostication in Advanced Mycosis Fungoides and Sézary Syndrome: The Role of the Cutaneous Lymphoma International Prognostic Index (CLIPI)

By MedXY|Oct 14, 2026

The Cutaneous Lymphoma International Prognostic Index (CLIPI) enhances risk stratification and predicts progression and treatment response beyond conventional staging in advanced mycosis fungoides and Sézary syndrome.

Enhanced Risk Stratification for Pediatric Tracheostomy Hospitalizations: Evaluating a Novel Tracheostomy-Specific Tier System
newsHospital Outcomesrisk stratification

Enhanced Risk Stratification for Pediatric Tracheostomy Hospitalizations: Evaluating a Novel Tracheostomy-Specific Tier System

By MedXY|Sep 29, 2026

A new tracheostomy-specific risk-tier system improves outcome prediction in pediatric tracheostomy hospitalizations compared with traditional severity metrics, offering better benchmarking for clinical care across institutions.

Soluble BCMA as a Key Biomarker Defining Tumor Phenotypes and Prognosis in Newly Diagnosed Multiple Myeloma
Hematology-Oncologyrisk stratificationprognosis

Soluble BCMA as a Key Biomarker Defining Tumor Phenotypes and Prognosis in Newly Diagnosed Multiple Myeloma

By MedXY|Sep 26, 2026

Soluble BCMA levels in newly diagnosed multiple myeloma patients reveal distinct tumor phenotypes and predict prognosis more strongly than tumor volume, enabling improved risk stratification and clinical decision-making.

MTMR4 Gene Variants: Divergent Impact on Arrhythmic Risk in Type 1 and 2 Long QT Syndrome
Cardiologyrisk stratificationArrhythmic risk

MTMR4 Gene Variants: Divergent Impact on Arrhythmic Risk in Type 1 and 2 Long QT Syndrome

By MedXY|Sep 25, 2026

MTMR4 minor allele homozygosity influences arrhythmic risk oppositely in LQT1 and LQT2, providing critical insights for personalized risk stratification in long QT syndrome patients.

Tailored Screening Intervals for Relatives Carrying TTN Truncations: Enhancing Dilated Cardiomyopathy Management
Cardiologyrisk stratificationgenetic screening

Tailored Screening Intervals for Relatives Carrying TTN Truncations: Enhancing Dilated Cardiomyopathy Management

By MedXY|Sep 23, 2026

A gene-specific, risk-based screening algorithm for relatives with titin-truncating variants optimizes monitoring intervals from 1 to 5 years, improving safety and resource use in dilated cardiomyopathy surveillance.

Standalone Salpingectomy for Primary Ovarian Cancer Prevention: A Cost-Effectiveness Analysis
Clinical Updatesrisk stratificationCost-Effectiveness

Standalone Salpingectomy for Primary Ovarian Cancer Prevention: A Cost-Effectiveness Analysis

By MedXY|Sep 23, 2026

This review synthesizes evidence on the cost-effectiveness of standalone salpingectomy for ovarian cancer prevention, highlighting its benefits primarily in women at moderately elevated risk, especially between ages 45-50, supporting tailor

Stratifying Risk for Further Retinal Intervention After Laser Retinopexy: The Impact of Cumulative Clinical Factors
newsvitreous hemorrhagerisk stratification

Stratifying Risk for Further Retinal Intervention After Laser Retinopexy: The Impact of Cumulative Clinical Factors

By MedXY|Sep 15, 2026

A novel, cumulative risk factor approach identifies patients at increased risk for additional retinal intervention after laser retinopexy for retinal tears, improving surveillance and management strategies.

β-Cell Dysfunction Enhances Prediction of Type 1 Diabetes Progression in Individuals with Single Autoantibody Positivity
Diabetes & Endocrinologyrisk stratificationtype 1 diabetes

β-Cell Dysfunction Enhances Prediction of Type 1 Diabetes Progression in Individuals with Single Autoantibody Positivity

By MedXY|Sep 14, 2026

Assessment of β-cell dysfunction using stimulated glucose and C-peptide measures improves risk stratification for type 1 diabetes progression among single autoantibody-positive relatives, enabling personalized monitoring and targeted interv

Physiological Left Atrial Staging as a Predictor of New-Onset Atrial Fibrillation in Hypertrophic Cardiomyopathy
Cardiologyrisk stratificationHypertrophic Cardiomyopathy

Physiological Left Atrial Staging as a Predictor of New-Onset Atrial Fibrillation in Hypertrophic Cardiomyopathy

By MedXY|Sep 14, 2026

A novel left atrial (LA) staging system, integrating hemodynamic load and contractile function, predicts new-onset atrial fibrillation risk in hypertrophic cardiomyopathy and may guide tailored AF surveillance.

Continuous Glucose Monitoring Using the FreeStyle Libre Pro iQ in Presymptomatic Type 1 Diabetes: Advancements in Early Detection and Risk Stratification
Clinical Updatesrisk stratificationtype 1 diabetes

Continuous Glucose Monitoring Using the FreeStyle Libre Pro iQ in Presymptomatic Type 1 Diabetes: Advancements in Early Detection and Risk Stratification

By MedXY|Sep 11, 2026

This review examines the role of FreeStyle Libre Pro iQ CGM in differentiating presymptomatic stages of type 1 diabetes and predicting progression to clinical disease, comparing its performance with Dexcom G6 and discussing implications for

Validated Risk Stratification for RYR2-Mediated Catecholaminergic Polymorphic Ventricular Tachycardia on Beta-Blocker Therapy
Cardiologyrisk stratificationCPVT

Validated Risk Stratification for RYR2-Mediated Catecholaminergic Polymorphic Ventricular Tachycardia on Beta-Blocker Therapy

By MedXY|Sep 6, 2026

This article reviews a validated clinical risk model predicting arrhythmic events in patients with RYR2-mediated CPVT receiving beta-blockers, facilitating personalized management to reduce life-threatening arrhythmias.

Enhancing Early Detection of Neonatal Hearing Loss: A Machine Learning Risk Stratification Approach
newsrisk stratificationXGBoost

Enhancing Early Detection of Neonatal Hearing Loss: A Machine Learning Risk Stratification Approach

By MedXY|Aug 31, 2026

This article discusses a novel machine learning-based tool, especially XGBoost, to predict hearing loss risk in high-risk neonates using clinical factors for targeted early intervention.

From Pressure Metrics to Personalized Prognosis: Transforming Risk Assessment in Advanced Chronic Liver Disease
GastroenterologyNon-invasive testsrisk stratification

From Pressure Metrics to Personalized Prognosis: Transforming Risk Assessment in Advanced Chronic Liver Disease

By MedXY|Aug 31, 2026

A shift from static portal pressure thresholds to dynamic, non-invasive risk prediction models offers improved prognostic accuracy for decompensation in advanced chronic liver disease, enabling personalized patient management and better cli

Advanced Right Ventricular Phenotyping Enhances Risk Stratification in Pulmonary Arterial Hypertension Follow-Up
Cardiologyrisk stratificationRight ventricular phenotyping

Advanced Right Ventricular Phenotyping Enhances Risk Stratification in Pulmonary Arterial Hypertension Follow-Up

By MedXY|Aug 27, 2026

Echocardiography-derived right ventricular phenotypes improve prognostic accuracy beyond standard risk tools in pulmonary arterial hypertension patients at first follow-up, refining survival predictions and guiding management strategies.

Integrated 40-Gene Expression Profile Enhances Prognostic Precision and Guides Adjuvant Radiation in High-Risk Cutaneous Squamous Cell Carcinoma
Dermatologyrisk stratificationadjuvant radiation therapy

Integrated 40-Gene Expression Profile Enhances Prognostic Precision and Guides Adjuvant Radiation in High-Risk Cutaneous Squamous Cell Carcinoma

By MedXY|Aug 26, 2026

The integrated 40-gene expression profile (i40-GEP) improves risk stratification in high-risk cutaneous squamous cell carcinoma, accurately predicting metastasis and local recurrence, and identifying patients who benefit most from adjuvant

Unveiling Hidden Immune Signatures in Cardiovascular Disease Through Single-Cell Multi-Omics
Allergy & Immunologycardiovascular diseaserisk stratification

Unveiling Hidden Immune Signatures in Cardiovascular Disease Through Single-Cell Multi-Omics

By MedXY|Aug 21, 2026

Single-cell multi-omics profiling reveals novel immune signatures linked to coronary artery disease and cardiovascular outcomes, independent of traditional inflammatory markers, offering new avenues for risk stratification and personalized

Risk Stratification Models in Blood or Marrow Transplant Recipients for Predicting Cutaneous Malignant Neoplasms
Dermatologyrisk stratificationBlood or marrow transplant

Risk Stratification Models in Blood or Marrow Transplant Recipients for Predicting Cutaneous Malignant Neoplasms

By MedXY|Aug 16, 2026

Blood or marrow transplant recipients face an increased risk of skin cancers. This study develops validated risk models to identify high-risk patients for basal cell carcinoma, squamous cell carcinoma, and melanoma to optimize surveillance

1 / 4
1234
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Cardiology
Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models